Allos

Accelerating clinical trials with our explainable Causal AI engine

[Allos @AllosBio]

We are honored to be the inaugural Silver Donor for @ConjectureInst.

Our Causal AI platform builds on the foundations pioneers like @yudapearl established.

We deeply believe in the institute's mission and proudly support the critical work of its incredible team and advisors.

[Conjecture Institute @ConjectureInst]

Conjecture Institute is proud to name @AllosBio as our first Silver Donor!

Led by CEO Aditya Iyer @IyerAditya, COO Isaac To @iZachTo, and CSO Ivano Lodato, Allos is an AI native pharmaceutical company reformulating drugs in the $90 billion complex generics market.

[Conjecture Institute @ConjectureInst]

Looking for work?

Check out our Job Board!

Friends of Conjecture Institute, @genzcash, @AllosBio, & @celestia, are open to working with those who share our values.

(link below)

[Judea Pearl @yudapearl]

Glad a company like @AllosBio recognizes the potentials of causal inference in drug development. @IyerAditya

[Conjecture Institute @ConjectureInst]

From Conjecture Institute Advisor @yudapearl's book, The Book of Why

The Ladder of Causation, with representative organisms at each level.

[Allos @AllosBio]

Major Announcement!

We'll be presenting at Berkeley @SkyDeck_Cal Demo Day, among other game-changing early stage companies.

Want to learn more? Read about it in VentureBeat. https://t.co/WAlCMY0LPF

Secure your invite here: https://t.co/5eX3I5ucH2

#SkyDeckDemoDay